Delivra Health Brands Inc. (DHB.V)

CAD 0.02

(0.0%)

Long Term Debt Summary of Delivra Health Brands Inc.

  • Delivra Health Brands Inc.'s latest annual long term debt in 2023 was 1.78 Million CAD , up 4.75% from previous year.
  • Delivra Health Brands Inc.'s latest quarterly long term debt in 2023 Q4 was 1.78 Million CAD , up 3.18% from previous quarter.
  • Delivra Health Brands Inc. reported annual long term debt of 1.7 Million CAD in 2022, up 1.97% from previous year.
  • Delivra Health Brands Inc. reported annual long term debt of 1.67 Million CAD in 2021, up 6.98% from previous year.
  • Delivra Health Brands Inc. reported quarterly long term debt of 1.73 Million CAD for 2023 Q3, up 3.53% from previous quarter.
  • Delivra Health Brands Inc. reported quarterly long term debt of 1.67 Million CAD for 2023 Q2, up 3.34% from previous quarter.

Annual Long Term Debt Chart of Delivra Health Brands Inc. (2023 - 2015)

Historical Annual Long Term Debt of Delivra Health Brands Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 1.78 Million CAD 4.75%
2022 1.7 Million CAD 1.97%
2021 1.67 Million CAD 6.98%
2020 1.56 Million CAD -24.9%
2019 2.08 Million CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%

Peer Long Term Debt Comparison of Delivra Health Brands Inc.

Name Long Term Debt Long Term Debt Difference
Aequus Pharmaceuticals Inc. 583.58 Thousand CAD -205.868%
CanadaBis Capital Inc. 5.91 Million CAD 69.829%
Decibel Cannabis Company Inc. 32.34 Million CAD 94.482%
Entourage Health Corp. 5.79 Million CAD 69.187%
Lifeist Wellness Inc. 868.65 Thousand CAD -105.49%
Cannara Biotech Inc. 39.73 Million CAD 95.508%
Medicure Inc. 229 Thousand CAD -679.476%
PharmaCielo Ltd. 2.55 Million CAD 30.094%
Rubicon Organics Inc. - CAD -Infinity%
BioSyent Inc. 1.03 Million CAD -72.01%
Voyageur Pharmaceuticals Ltd. 40 Thousand CAD -4362.5%